Track topics on Twitter Track topics that are important to you
212 Carnegie CenterSuite 101
United States of America
Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) und Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx) gaben Read more...
NOVATO, Calif. and TOKYO and LONDON, May 17, 2018 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products fo...
NOVATO, Calif. and TOKYO and LONDON, April 17, 2018 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel produ...
Tokyo, Japan, May 30, 2018 –Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and COO: Masashi Miyamoto, “Kyowa Hakko Kirin”) announced today that it has been notified that the U.S. Food and Dr...
Fujifilm Kyowa Kirin Biologics Co. Ltd. gab heute bekannt, dass das Unternehmen mit Mylan N.V. (NASDAQ:MYL) zusammenarbeiten wird, um FKB327, ein von Fujifilm Kyowa Kirin Biologics entwickeltes Bi...
The coming of the new year has brought a flurry of executive changes. GSK Japan has a new president, Kyowa...
US ultra-rare diseases focussed biotech firm Ultragenyx Pharmaceutical and Japan’s Kyowa Hakko Kirin…
Japan’s Kyowa Hakko Kirin and US biotech Ultragenyx Pharmaceutical today announced that Crysvita (burosumab)…
Cetirizine Hydrochloride Syrup
Burosumab (Crysvita; Kyowa Hakko Kirin Co., Ltd. and Ultragenyx Pharmaceutical Inc.) is a fully human monoclonal antibody directed at fibroblast growth factor 23 (FGF23). Excessive FGF23 production ha...
The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...
This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...
Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...
The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...
The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...
The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients
From its foundation in 1949, Kyowa Hakko has been a global leader in the pharmaceutical industry. Today, Kyowa's expertise extends to the United States through Kyowa Pharmaceutical, Inc. headquartered...
We have published hundreds of Kyowa Pharmaceutical, Inc news stories on BioPortfolio along with dozens of Kyowa Pharmaceutical, Inc Clinical Trials and PubMed Articles about Kyowa Pharmaceutical, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kyowa Pharmaceutical, Inc Companies in our database. You can also find out about relevant Kyowa Pharmaceutical, Inc Drugs and Medications on this site too.